PI
-
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups
Dubbelman, M. A., Hendriksen, H. M. A., Harrison, J. E., Vijverberg, E. G. B., Prins, N. D., Kroeze, L. A., Ottenhoff, L., Van Leeuwenstijn, M. M. S. S. A., Verberk, I. M. W., Teunissen, C. E., Van Harten, A. C., Van Der Flier, W. M., Sikkes, S. A. M. & van de Giessen, E. M., 23 Jan 2024, In: Neurology. 102, 2, p. e207978Research output: Contribution to journal › Article › Academic › peer-review
-
Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer’s Disease
Cantillon, M., Andreasen, N. & Prins, N., Jan 2024, In: Journal of Prevention of Alzheimer's Disease. 11, 1, p. 65-70 6 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands
Ottenhoff, L., Vijverberg, E. G. B., Visser, L. N. C., Verijp, M., Prins, N. D., Van der Flier, W. M. & Sikkes, S. A. M., 1 Dec 2023, In: Alzheimer's Research and Therapy. 15, 1, p. 72 1 p., 72.Research output: Contribution to journal › Article › Academic › peer-review
- All publications